XERISOL Trademark

Trademark Overview

On Monday, May 15, 2017, a trademark application was filed for XERISOL with the United States Patent and Trademark Office. The USPTO has given the XERISOL trademark a serial number of 87450263. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 11, 2021. This trademark is owned by Xeris Pharmaceuticals, Inc.. The XERISOL trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives, vaccines, antineoplastic pharmaceutical preparations, and immunomodulating pharmaceutical preparations

pharmaceutical research and development; pharmaceutical drug formulation and development services
xerisol

General Information

Serial Number87450263
Word MarkXERISOL
Filing DateMonday, May 15, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous system diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions, namely, anti-invectives, vaccines, antineoplastic pharmaceutical preparations, and immunomodulating pharmaceutical preparations
Goods and Servicespharmaceutical research and development; pharmaceutical drug formulation and development services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 19, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 19, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXeris Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60601
Party NameXeris Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78705

Trademark Events

Event DateEvent Description
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, May 19, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, January 11, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 11, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 24, 2020SOU EXTENSION 5 GRANTED
Thursday, June 4, 2020SOU EXTENSION 5 FILED
Tuesday, June 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 4, 2020TEAS EXTENSION RECEIVED
Friday, May 22, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 22, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 22, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 22, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 22, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 3, 2019SOU EXTENSION 4 GRANTED
Tuesday, December 3, 2019SOU EXTENSION 4 FILED
Tuesday, December 3, 2019TEAS EXTENSION RECEIVED
Thursday, June 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 4, 2019SOU EXTENSION 3 GRANTED
Tuesday, June 4, 2019SOU EXTENSION 3 FILED
Tuesday, June 4, 2019TEAS EXTENSION RECEIVED
Friday, November 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 31, 2018SOU EXTENSION 2 GRANTED
Wednesday, October 31, 2018SOU EXTENSION 2 FILED
Wednesday, October 31, 2018TEAS EXTENSION RECEIVED
Wednesday, June 27, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 27, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 31, 2018ASSIGNED TO EXAMINER
Saturday, May 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 10, 2018SOU EXTENSION 1 GRANTED
Thursday, May 10, 2018SOU EXTENSION 1 FILED
Thursday, May 10, 2018TEAS EXTENSION RECEIVED
Tuesday, December 5, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 5, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 21, 2017EXAMINER'S AMENDMENT ENTERED
Monday, August 21, 2017ASSIGNED TO LIE
Monday, August 21, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 21, 2017EXAMINERS AMENDMENT E-MAILED
Monday, August 21, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, August 14, 2017ASSIGNED TO EXAMINER
Friday, May 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 18, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

xerisol pharmaceutical preparations diseases conditions development namely treatment antineoplastic research immunomodulating